Renaissance Technologies - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 50 filers reported holding NEOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$673,000
+32.0%
1,076,683
+12.0%
0.00%0.0%
Q3 2020$510,000
-9.6%
960,900
+16.7%
0.00%
Q2 2020$564,000
+7.2%
823,143
+17.4%
0.00%
-100.0%
Q1 2020$526,000
-47.8%
701,243
+5.2%
0.00%0.0%
Q4 2019$1,007,000
+66.7%
666,868
+63.4%
0.00%0.0%
Q3 2019$604,000
+230.1%
408,162
+188.3%
0.00%
Q2 2019$183,000
-34.4%
141,555
+32.3%
0.00%
Q1 2019$279,000
-54.2%
106,968
+151.7%
0.00%
-100.0%
Q4 2015$609,00042,5000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders